PacBio's New CEO Talks Priorities at JP Morgan Conference | GenomeWeb

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – Pacific Biosciences' new CEO Michael Hunkapiller addressed investors at the JP Morgan Healthcare Conference Wednesday, offering some insight into the firm's priorities and the reason behind the change at the top of the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.